Given the in vivo anti-angiogenic activity of HSA/TIMP-2, we explored the regulatory effects of HSA/TIMP-2 on MMP-2, a key regulator of tumor angiogenesis known to be modulated through an interaction with TIMP-2 [32], [33]. This evidence concerns the gene TIMP2 and neoplasm.